Description
PNC-27 5MG supplied by PureTy Peptides for qualified laboratory buyers. Modality: Injectable; presentation: 5MG.
Areas of research interest
- Selective cancer cell killing *
- Potentially targets multiple cancer types
- Activity independent of p53 mutation status
- Mitochondrial effects
Specifications
- Modality: Injectable
- Presentation: 5MG
- Purity target: ≥99% (batch-specific COA available on request)
For research use only. Not for human or animal use.
Reviews
There are no reviews yet.